Maurice Leibman
Gynecology · Houston, TXNPI 1023017001
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (55.9%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 35 manufacturers reported payments, led by Ascend Therapeutics US, LLC at 35.2% of the total. Among gynecology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 381 payments — averaging $25.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ascend Therapeutics US, LLC$3K
- Acessa Health Inc.$1K
- Novo Nordisk$858
- AbbVie$668
- Therapeuticsmd, Inc.$612
- Amgen$409
- plus $3K from 29 others
What the payments were for
- Consulting fees$1,50016%
- Speaking & faculty fees$1,50016%
- Travel & lodging$8719%
- Food & beverage$5,34656%
- Education$2433%
- Gifts$1101%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ascend Therapeutics US, LLC | 155 | $3,369 |
| Acessa Health Inc.(2 entities) | 5 | $1,088 |
| Novo Nordisk | 23 | $858 |
| AbbVie(2 entities) | 25 | $668 |
| Therapeuticsmd, Inc. | 29 | $612 |
| Amgen | 9 | $409 |
| Mayne Pharma Commercial LLC | 12 | $306 |
| Pfizer | 16 | $269 |
| AMAG Pharmaceuticals, Inc. | 18 | $220 |
| Myovant Sciences Inc. | 8 | $193 |
| Vertical Pharmaceuticals, LLC | 12 | $177 |
| Davol Inc. | 1 | $162 |
| Currax Pharmaceuticals LLC | 11 | $152 |
| Exeltis, USA Inc. | 10 | $152 |
| Lupin Inc. | 7 | $119 |
| Avion Pharmaceuticals | 5 | $98 |
| Kowa Pharmaceuticals America, Inc. | 4 | $91 |
| Bayer | 3 | $82 |
| Sumitomo Pharma America, Inc. | 3 | $82 |
| Astellas Pharma US Inc | 3 | $61 |
| Evofem Biosciences, Inc. | 3 | $59 |
| Millicent US Inc | 3 | $46 |
| Hologic Sales And Service, LLC | 2 | $45 |
| Organon | 2 | $38 |
| Idorsia Pharmaceuticals US Inc | 2 | $31 |
| Merck | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Scynexis, Inc. | 1 | $21 |
| Allotrope Medical, Inc | 1 | $20 |
| Shire North American Group Inc | 1 | $18 |
| Eisai Inc. | 1 | $18 |
| Pacira Pharmaceuticals Incorporated | 1 | $18 |
| Gynesonics, Inc. | 1 | $15 |
| Agile Therapeutics, Inc. | 1 | $11 |
| Nalpropion Pharmaceuticals LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ESTROGEL$3,000
- Acessa$871
- Saxenda$457
- EVENITY$220
- ARISTA AH FLEXITIP$162
- ACESSA PROVU SYSTEM$120
- Orilissa$118
- Wegovy$116
- IMVEXXY$112
How this compares
$9,570 in reported general payments places this provider in the 90th percentile of 161 gynecology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol (Twice Weekly)Estradiol | 16 | $2,676 |
| ProgesteroneProgesterone, Micronized | 11 | $445 |
Paid to pharmacies, not to this prescriber.
Other gynecology in Houston
- Robert ZurawinHouston$61K
- Nicolas XydasHouston$19K
- Glenn MorganHouston$7K
- Alfred PoindexterHouston$5K
- Pinky RonenHouston$4K
- M Bruce ChristophersonHouston$3K
- John IrwinHouston$2K
- Richard FarnamEl Paso$1.2M
- Jessica ShepherdDallas$809K
- Linda LacyEl Paso$627K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.